8-K: SINTX Technologies Appoints CEO Eric K. Olson to Board of Directors
Director Appointment
SINTX Technologies has appointed its current CEO, Eric K. Olson, to its Board of Directors, effective November 22, 2024.
Summary
- SINTX Technologies has appointed Eric K. Olson, the current Chief Executive Officer and President, to its Board of Directors.
- The appointment was effective as of November 22, 2024.
- Mr. Olson has served as the company's CEO and President since August 2024.
- Prior to his current role, Mr. Olson held leadership positions at Foresite Innovations, Predictive Biotech, and Skeletal Kinetics.
- He also previously served as CEO and President of SINTX Technologies (formerly Amedica Corporation) from 2012 to 2014.
- Mr. Olson has a background in sales and marketing leadership with companies like Smith & Nephew, Johnson & Johnson, Medtronic, and Wright Medical.
- He holds Bachelor of Science degrees in Behavioral Science and Health Administration from The University of Utah.
Sentiment
Score: 7
Explanation: The document reflects a positive corporate governance move, with the CEO joining the board. This is generally seen as a positive step for alignment and strategic direction.
Positives
- The appointment of the current CEO to the board may improve alignment between management and the board.
- Mr. Olson's extensive experience in the medical device industry could benefit the company's strategic direction.
- His previous experience as CEO of SINTX Technologies provides valuable historical knowledge.
Industry Context
The appointment of a CEO to the board is a common practice in corporate governance, aiming to align management and board strategies. Mr. Olson's background in medical devices is relevant to SINTX's business.
Comparison to Industry Standards
- Many companies in the medical device industry have their CEO on the board to ensure strategic alignment.
- This move is consistent with standard corporate governance practices in similar publicly traded companies.
- Companies like Medtronic and Johnson & Johnson, where Mr. Olson previously worked, often have their CEOs on the board.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board of Directors | N/A | Eric K. Olson | November 22, 2024 | Appointment of current CEO to the board |
Stakeholder Impact
- Shareholders may view this appointment positively as it aligns management and board interests.
- Employees may see this as a sign of stability and strategic direction.
Key Dates
| Date | Description |
|---|---|
| 2012-02 | Eric K. Olson served as Chief Executive Officer and President and a member of the board of directors of SINTX Technologies (formerly Amedica Corporation). |
| 2014-09 | Eric K. Olson ceased to be Chief Executive Officer and President and a member of the board of directors of SINTX Technologies (formerly Amedica Corporation). |
| 2014-12 | Eric K. Olson was the President and Chief Executive Officer for Skeletal Kinetics. |
| 2016-01 | Eric K. Olson ceased to be the President and Chief Executive Officer for Skeletal Kinetics. |
| 2016-01 | Eric K. Olson was the founder, President, Chief Executive Officer and Board Member of Predictive Biotech, Inc. |
| 2022-06 | Eric K. Olson ceased to be the founder, President, Chief Executive Officer and Board Member of Predictive Biotech, Inc. |
| 2022-06 | Eric K. Olson was the Founder, Chief Executive Officer and Board Member of Foresite Innovations, LLC. |
| 2024-08 | Eric K. Olson ceased to be the Founder, Chief Executive Officer and Board Member of Foresite Innovations, LLC and became the Chief Executive Officer and President of SINTX Technologies. |
| 2024-11-22 | Eric K. Olson was appointed to the Board of Directors of SINTX Technologies. |
| 2024-11-29 | Date of report signature. |
Keywords
Board of Directors, CEO, Eric K. Olson, SINTX Technologies, Corporate Governance, Medical Devices, Executive Appointment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.